NASDAQ:DH Definitive Healthcare (DH) Stock Forecast, Price & News $7.89 +0.09 (+1.15%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$7.78▼$8.0450-Day Range$7.77▼$12.1052-Week Range$7.58▼$17.39Volume490,273 shsAverage Volume745,405 shsMarket Capitalization$893.94 millionP/E RatioN/ADividend YieldN/APrice Target$12.69 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Definitive Healthcare MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside60.8% Upside$12.69 Price TargetShort InterestBearish20.03% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.88Based on 3 Articles This WeekInsider TradingSelling Shares$62,500 Sold Last QuarterProj. Earnings Growth166.67%From $0.03 to $0.08 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.46 out of 5 starsMedical Sector172nd out of 976 stocksPrepackaged Software Industry48th out of 202 stocks 4.3 Analyst's Opinion Consensus RatingDefinitive Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $12.69, Definitive Healthcare has a forecasted upside of 60.8% from its current price of $7.89.Amount of Analyst CoverageDefinitive Healthcare has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 0.0 Short Interest Percentage of Shares Shorted20.03% of the float of Definitive Healthcare has been sold short.Short Interest Ratio / Days to CoverDefinitive Healthcare has a short interest ratio ("days to cover") of 14.3, which indicates bearish sentiment.Change versus previous monthShort interest in Definitive Healthcare has recently increased by 24.84%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldDefinitive Healthcare does not currently pay a dividend.Dividend GrowthDefinitive Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DH. Previous Next 2.7 News and Social Media Coverage News SentimentDefinitive Healthcare has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Definitive Healthcare this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for DH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Definitive Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $62,500.00 in company stock.Percentage Held by Insiders15.27% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Definitive Healthcare are expected to grow by 166.67% in the coming year, from $0.03 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Definitive Healthcare is -52.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Definitive Healthcare is -52.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDefinitive Healthcare has a PEG Ratio of 11.28. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDefinitive Healthcare has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Definitive Healthcare (NASDAQ:DH) StockDefinitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.Read More DH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DH Stock News HeadlinesSeptember 12, 2023 | seekingalpha.comDefinitive Healthcare: Fundamentals Remain Sound But Stock Sentiment Is BadSeptember 8, 2023 | finance.yahoo.comDefinitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 28, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...September 8, 2023 | finance.yahoo.comDefinitive Healthcare Welcomes Scott Stephenson to Board of DirectorsSeptember 5, 2023 | finance.yahoo.comDefinitive Healthcare to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceAugust 21, 2023 | finance.yahoo.comWhat Makes Definitive Healthcare Corp. (DH) an Attractive Investment?August 18, 2023 | fool.comDefinitive Healthcare (NASDAQ: DH)August 16, 2023 | msn.comGoldman Sachs Maintains Definitive Healthcare Corp - (DH) Neutral RecommendationSeptember 28, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...August 15, 2023 | finanznachrichten.deDefinitive Healthcare Corp.: Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023August 15, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH), Clearside Biomedical (CLSD) and Biora Therapeutics (BIOR)August 15, 2023 | markets.businessinsider.comGoldman Sachs Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)August 14, 2023 | axios.comExclusive: Definitive Healthcare to buy analytics startup Populi for $52M cashAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare expands Atlas Technology Install DatasetAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare acquires PopuliAugust 14, 2023 | finance.yahoo.comDefinitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023August 11, 2023 | benzinga.comDefinitive Healthcare Corp.: Company Investigated by the Portnoy Law FirmAugust 10, 2023 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Definitive Healthcare Corp. - DHAugust 3, 2023 | benzinga.comEarnings Preview For Definitive HealthcareAugust 1, 2023 | seekingalpha.comDefinitive Healthcare Q2 revenue in-line with consensusAugust 1, 2023 | finance.yahoo.comDefinitive Healthcare Reports Preliminary Financial Results for Second Quarter Fiscal Year 2023, Reaffirms Full Year Guidance for Revenue and Adjusted EBITDA, and Announces Restatement of Previously Issued FinancialsJuly 24, 2023 | msn.comDefinitive Healthcare slips on Baird downgradeJuly 24, 2023 | msn.comBaird Downgrades Definitive Healthcare Corp - (DH)July 24, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Definitive HealthcareJuly 24, 2023 | investing.comBaird says Q2 Holdings better-than-anticipated, nCino and Definitive Healthcare have more balanced risk/rewardJuly 13, 2023 | finance.yahoo.comDefinitive Healthcare Announces Timing of Its Second Quarter 2023 Financial Results Conference Call and WebcastJune 28, 2023 | finance.yahoo.comDefinitive Healthcare expands the Atlas DatasetSee More Headlines Receive DH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address DH Company Calendar Last Earnings8/14/2023Today9/28/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Prepackaged software Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:DH CUSIPN/A CIK1861795 Webwww.definitivehc.com Phone508-720-4224FaxN/AEmployees946Year FoundedN/APrice Target and Rating Average Stock Price Forecast$12.69 High Stock Price Forecast$15.50 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+60.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E Ratio263.00 P/E Growth11.28Net Income$-7,220,000.00 Net Margins-5.31% Pretax Margin-20.08% Return on Equity0.29% Return on Assets0.20% Debt Debt-to-Equity Ratio0.17 Current Ratio2.84 Quick Ratio2.84 Sales & Book Value Annual Sales$222.65 million Price / Sales4.01 Cash Flow$0.70 per share Price / Cash Flow11.28 Book Value$14.10 per share Price / Book0.56Miscellaneous Outstanding Shares113,300,000Free Float95,998,000Market Cap$893.94 million OptionableNot Optionable Beta0.74 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jason Ronald Krantz (Age 49)Founder & Exec. Chairman Comp: $820.92kMr. Robert W. Musslewhite J.D. (Age 53)CEO & Director Comp: $709.08kMr. Jon MaackPresMr. Richard Douglas Booth (Age 54)Chief Financial Officer Comp: $562.44kMr. Joseph Gianni Mirisola (Age 39)Chief Revenue Officer Comp: $402.2kMs. Kate Marie Shamsuddin Jensen (Age 37)Chief Product Officer Comp: $393.26kMr. Scott OberlinkChief Technology OfficerMr. Matt RudermanChief Legal Officer & Sec.Mr. Justin A. SteinmanChief Marketing OfficerMr. Ram SharmaExec. VP of Life SciencesMore ExecutivesKey CompetitorsCertaraNASDAQ:CERTArdelyxNASDAQ:ARDXEmbectaNASDAQ:EMBCAgilitiNYSE:AGTIInhibrxNASDAQ:INBXView All CompetitorsInsiders & InstitutionsBarclays PLCSold 31,780 shares on 9/21/2023Ownership: 0.015%Sea Vii Management, LlcSold 6,656 sharesTotal: $62,499.84 ($9.39/share)California State Teachers Retirement SystemBought 7,762 shares on 8/21/2023Ownership: 0.047%Osaic Holdings Inc.Bought 1,119 shares on 8/21/2023Ownership: 0.025%Nuveen Asset Management LLCBought 21,996 shares on 8/16/2023Ownership: 0.084%View All Insider TransactionsView All Institutional Transactions DH Stock - Frequently Asked Questions Should I buy or sell Definitive Healthcare stock right now? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" DH shares. View DH analyst ratings or view top-rated stocks. What is Definitive Healthcare's stock price forecast for 2023? 8 equities research analysts have issued 1-year target prices for Definitive Healthcare's stock. Their DH share price forecasts range from $10.00 to $15.50. On average, they expect the company's share price to reach $12.69 in the next year. This suggests a possible upside of 60.8% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts. How have DH shares performed in 2023? Definitive Healthcare's stock was trading at $10.99 at the start of the year. Since then, DH stock has decreased by 28.2% and is now trading at $7.89. View the best growth stocks for 2023 here. Are investors shorting Definitive Healthcare? Definitive Healthcare saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 7,990,000 shares, an increase of 24.8% from the August 31st total of 6,400,000 shares. Based on an average daily volume of 556,900 shares, the days-to-cover ratio is presently 14.3 days. Currently, 20.0% of the company's shares are sold short. View Definitive Healthcare's Short Interest. When is Definitive Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our DH earnings forecast. How were Definitive Healthcare's earnings last quarter? Definitive Healthcare Corp. (NASDAQ:DH) released its earnings results on Monday, August, 14th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. The firm had revenue of $60.96 million for the quarter, compared to analyst estimates of $61 million. Definitive Healthcare had a negative net margin of 5.31% and a positive trailing twelve-month return on equity of 0.29%. The firm's revenue was up 11.7% on a year-over-year basis. During the same period last year, the business earned ($0.01) earnings per share. What ETFs hold Definitive Healthcare's stock? ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Definitive Healthcare issued on next quarter's earnings? Definitive Healthcare updated its third quarter 2023 earnings guidance on Monday, August, 14th. The company provided earnings per share guidance of $0.05-$0.07 for the period, compared to the consensus EPS estimate of $0.05. The company issued revenue guidance of $63.00 million-$64.50 million, compared to the consensus revenue estimate of $64.24 million. When did Definitive Healthcare IPO? (DH) raised $350 million in an initial public offering on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share. What is Definitive Healthcare's stock symbol? Definitive Healthcare trades on the NASDAQ under the ticker symbol "DH." Who are Definitive Healthcare's major shareholders? Definitive Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (4.94%), JPMorgan Chase & Co. (4.62%), Brown Advisory Inc. (3.58%), BlackRock Inc. (3.38%), Riverbridge Partners LLC (2.63%) and Clearbridge Investments LLC (2.06%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc. View institutional ownership trends. How do I buy shares of Definitive Healthcare? Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Definitive Healthcare's stock price today? One share of DH stock can currently be purchased for approximately $7.89. How much money does Definitive Healthcare make? Definitive Healthcare (NASDAQ:DH) has a market capitalization of $893.94 million and generates $222.65 million in revenue each year. The company earns $-7,220,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. How many employees does Definitive Healthcare have? The company employs 946 workers across the globe. How can I contact Definitive Healthcare? Definitive Healthcare's mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for the company is www.definitivehc.com. The company can be reached via phone at 508-720-4224 or via email at ir@definitivehc.com. This page (NASDAQ:DH) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.